Moran, Claus Aagaard Nielsen, Mikkel Due Petersen, Lars Nygaard, David rsted, Christian Poulsen, Tina Secher Rasmussen, and Else Marie Agger (Novo Nordisk A/S, Denmark) for review of and input to the manuscript, and to Alexander Jones, PhD, CMPP TM and Sola Neunie, MSc, CMPP TM from AXON Communications (supported by Novo Nordisk) for writing assisstance
It can be specified in a number of ways depending upon the Depth of Discharge (DOD) and C-Rate
California Infusion Centers provides mobile IV therapy throughout the San Fernando Valley for people who want hydration and nutrient support without rearranging their entire day
It is not intended for human consumption, veterinary use, cosmetic applications, therapeutic use, or diagnostic purposes